• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA R2P MISAGO RX SELF-EXPANDING PERIPHERAL STENT; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA R2P MISAGO RX SELF-EXPANDING PERIPHERAL STENT; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number N/A
Medical Device Problem Code Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/31/2022
Type of Reportable Event Serious Injury
Event or Problem Description
The user facility reported that a 6x100 misago was deployed in distal superficial femoral artery (sfa) area where some plaque dissection was present.Upon deployment the proximal end of the stent appeared to be crimped.This malformation of deployment was not flow limiting, however it was a concern for the doctor after placement.He further investigated and showed under intravascular ultrasound (ivus) that the fluoroscopy image was confirmed, and the top of the stent was crimped.The doctor was not satisfied with the stent and realigned the misago with a 6x40 zilver ptx stent.The artery of the lower extremity was not previously treated.Right superficial femoral artery (sfa) was diseased limb.Site of the puncture was the femoral artery contralateral via antegrade approach.The lesion length 100, with a 5mm vessel diameter.The patient was stable, and the procedure outcome was successful.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
R2P MISAGO RX SELF-EXPANDING PERIPHERAL STENT
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
MDR Report Key18239352
Report Number2243441-2022-00035
Device Sequence Number6983888
Product Code NIP
UDI-Device Identifier04987350727541
UDI-Public04987350727541
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Importer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 11/30/2023
Report Date (Section F) 11/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2022
Device Model NumberN/A
Device Catalogue NumberSXR06100R
Device Lot Number191204
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date06/01/2022
Device Age2 YR
Event Location Hospital
Date Report to Manufacturer06/02/2022
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date11/30/2023
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
Date Report Sent to FDA11/30/2023
-
-